A presidential order to establish the Biohealth Innovation Committee, a control tower to foster the pharmaceutical bio-industry, has been issued. The government plans to hold its first meeting next month to begin discussing major agendas.

With the launch of a pan-ministerial organization, financial and administrative support is expected to be strengthened in addition to support for domestic pharmaceutical and bio companies' research and development (R&D), new drug development, and entry into overseas markets.

The Ministry of Health and Welfare announced on the 17th that regulations regarding the establishment and operation of the Biohealth Innovation Committee (Presidential Order No. 461) ha